Amanda Blackford
Overview
Explore the profile of Amanda Blackford including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
2746
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fierro-Pineda J, Tsai H, Blackford A, Cluster A, Caywood E, Dalal J, et al.
Blood Adv
. 2023 May;
7(18):5639-5648.
PMID: 37257193
Promising results have been reported for adult patients with high-risk hematologic malignancies undergoing haploidentical bone marrow transplant (haploBMT) with posttransplant cyclophosphamide (PTCy). To our knowledge, we report results from the...
2.
Snyder C, Hannum S, White S, Montanari A, Ikejiani D, Smith B, et al.
Qual Life Res
. 2022 Feb;
31(8):2341-2355.
PMID: 35133567
Purpose: PRO-cision medicine refers to personalizing care using patient-reported outcomes (PROs). We developed and feasibility-tested a PRO-cision Medicine remote PRO monitoring intervention designed to identify symptoms and reduce the frequency...
3.
Tang H, Jiang L, Stolzenberg-Solomon R, Arslan A, Beane Freeman L, Bracci P, et al.
Cancer Epidemiol Biomarkers Prev
. 2020 Jun;
29(9):1784-1791.
PMID: 32546605
Background: Obesity and diabetes are major modifiable risk factors for pancreatic cancer. Interactions between genetic variants and diabetes/obesity have not previously been comprehensively investigated in pancreatic cancer at the genome-wide...
4.
Berger Z, Tung M, Yesantharao P, Zhou A, Blackford A, Smith T, et al.
J Patient Rep Outcomes
. 2019 Aug;
3(1):53.
PMID: 31418088
Introduction: Management of cancer is often characterized by difficult decisions. The National Coalition for Cancer Survivorship (NCCS) has developed the "Know Yourself" tool, a question prompt list (QPL) to enable...
5.
Canto M, Kerdsirichairat T, Yeo C, Hruban R, Shin E, Almario J, et al.
J Gastrointest Surg
. 2019 Jun;
24(5):1101-1110.
PMID: 31197699
Background: Screening high-risk individuals (HRI) can detect potentially curable pancreatic ductal adenocarcinoma (PDAC) and its precursors. We describe the outcomes of high-risk individuals (HRI) after pancreatic resection of screen-detected neoplasms....
6.
Canto M, Almario J, Schulick R, Yeo C, Klein A, Blackford A, et al.
Gastroenterology
. 2018 May;
155(3):740-751.e2.
PMID: 29803839
Background & Aims: Screening of individuals who have a high risk of pancreatic ductal adenocarcinoma (PDAC), because of genetic factors, frequently leads to identification of pancreatic lesions. We investigated the...
7.
Chandler F, Kane J, Blackford A, Weinberger M, Wagner K, Gojo I, et al.
Oncol Nurs Forum
. 2018 Feb;
45(2):177-186.
PMID: 29466342
Objectives: To identify predictive signs and symptoms occurring in hospitalized adults with hematologic malignancies with intracranial hemorrhage (IH).
. Sample & Setting: In a National Cancer Institute (NCI)-designated comprehensive cancer...
8.
Klein A, Wolpin B, Risch H, Stolzenberg-Solomon R, Mocci E, Zhang M, et al.
Nat Commun
. 2018 Feb;
9(1):556.
PMID: 29422604
In 2020, 146,063 deaths due to pancreatic cancer are estimated to occur in Europe and the United States combined. To identify common susceptibility alleles, we performed the largest pancreatic cancer...
9.
Brundage M, Blackford A, Tolbert E, Smith K, Bantug E, Snyder C
Qual Life Res
. 2017 Nov;
27(1):75-90.
PMID: 29098606
Purpose: Patient-reported outcome (PRO) results from clinical trials can inform clinical care, but PRO interpretation is challenging. We evaluated the interpretation accuracy and perceived clarity of various strategies for displaying...
10.
Smith K, Tolbert E, Hannum S, Radhakrishnan A, Zorn K, Blackford A, et al.
JMIR Cancer
. 2017 Apr;
2(2):e12.
PMID: 28410187
Background: Survivorship care plans (SCPs) are intended to facilitate communication and coordination between patients, oncologists, and primary care providers. Most SCP initiatives have focused on oncology providers initiating the SCP...